Primary lymphoma arising in the nasal cavity among Japanese

Histopathology

Volumn 47, Issue 5, 2005, Pages 523-532

  Kitamura, A ^a   Yamashita, Y ^a   Hasegawa, Y ^b   Kojima, H ^b   Nagasawa, T ^b   Mori, Naoyoshi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Nasal lymphoma; NK cell; NK T cell; NKT cell

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GRANZYME B; RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; JAPAN; LYMPHOMA; MALE; NATURAL KILLER CELL; NOSE CAVITY TUMOR; PLASMACYTOMA; PRIORITY JOURNAL; SCHOOL CHILD; T CELL LYMPHOMA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NASAL CAVITY; NOSE NEOPLASMS;

HUMAN HERPESVIRUS 4;

EID: 27744482563     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02265.x     Document Type: Article

References (44)

1. Ho FC, Choy D, Loke SL et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum. Pathol. 1990; 21; 1041-1050.
2. Jaffe ES, Chan JK, Su IJ et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. Am. J. Surg. Pathol. 1996; 20; 103-111.
3. Gaal K, Weiss LM, Chen WG, Chen YY, Arber DA. Epstein-Barr virus nuclear antigen (EBNA)-1 carboxy-terminal and EBNA-4 sequence polymorphisms in nasal natural killer/T-cell lymphoma in the United States. Lab. Invest. 2002; 82; 957-962.
4. Chan JK, Jaffe ES, Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type. In Jaffe ES, Harris NL, Stein H, Vardiman JM eds. World Health Organization classification of tumours: pathology and genetics, tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press 2001; 204-207.
5. Ferry JA, Sklar J, Zukerberg LR, Harris NL. Nasal lymphoma. A clinicopathologic study with immunophenotypic and genotypic analysis. Am. J. Surg. Pathol. 1991; 15; 268-279.
6. Liang R, Todd D, Chan TK et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J. Clin Oncol. 1995; 13; 666-670.
7. Yu KH, Yu SC, Teo PM et al. Nasal lymphoma: results of local radiotherapy with or without chemotherapy. Head Neck 1997; 19; 251-259.
8. Suzumiya J, Ohshima K, Takeshita M et al. Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene. Leuk. Lymphoma 1999; 35; 567-578.
9. Mori N, Yatabe Y, Oka K et al. Expression of perform in nasal lymphoma. Additional evidence of its NK cell derivation. Am. J. Pathol. 1996; 149; 699-705.
10. Mclean IW, Nakane PK. Periodate-lysine-paraformaldehyde fizative: a new fixative for immunoelectron microscopy. J. Histochem. Cytochem. 1974; 22; 1077-1083.
11. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981; 29; 577-580.
12. Tsunoda R, Terashima K, Takahashi K, Kojima M. An ultrastructural study with enzyme-labeled antibody technique on immunoglobulin containing cells in human tonsils, especially in germinal centers. Acta. Pathol. Jpn 1978; 28; 53-75.
13. Chang KL, Chen YY, Shibata D, Weiss L. Description of an in situ Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn. Mol. Pathol. 1990; 1; 246-255.
14. Suzumiya J, Takeshita M, Kimura N et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood 1994; 83; 2255-2260.
15. Yamaguchi M, Ohno T, Oka K et al. Discordant reaction of Leu4 and rabbit anti-human CD3ε in sinonasal T-cell lymphoma. Int. J. Hematol. 1993; 59; 25-30.
16. Chan JK, Tsang WY, Ng CS, Pau MY. Discordant CD3 expression in lymphomas when studied on frozen and paraffin tissue sections. Hum. Pathol. 1995; 26; 1139-1143.
17. Ohno T, Yamaguchi M, Oka K, Miwa H, Kita K, Shirakawa S, Frequent expression of CD3ε in CD3 (Leu4)-negative nasal T-cell lymphomas. Leukemia 1995; 9: 44-52.
18. Abbondanzo SL, Wenig BM. Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases. Cancer 1995; 75; 1281-1291.
19. Lanier LL, Chang C, Spitz H, Phillips JH. Expression of cytoplasmic CD3ε proteins in activated human adult natural killer cells (NK cells) and CD3γ, α, ε complexes in fetal NK cells. J. Immunol. 1992; 149; 1876-1880.
20. Salmeron A, Sanchez-Madrid F, Ursa MA, Fresno M, Alarcon B. A conformational epitope expressed upon association of CD3-ε with either CD3-δ or CD3-γ is the main target for recognition by anti-CD3 monoclonal antibodies. J. Immunol. 1991; 147: 3047-3052.
21. Phillips JH, Hori T, Nagler A et al. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3ε, δ proteins. J. Exp. Med. 1992; 175; 1055-1066.
22. + cells neoplastic or reactive? Blood 1995; 85; 2993-2994.
23. + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996; 87; 1466-1473.
24. Young JD, Hengartner H, Podack ER, Cohn ZA. Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell 1986; 44; 849-859.
25. Griffiths GM, Mueller C. Expression of perform and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. Immunol. Today 1991; 12; 415-419.
26. Kawakami A, Tian Q, Duan X et al. Identification and functional characterization of a TLA-1-related nucleolysin. Proc. Natl Acad. Sci. USA 1992; 89; 8681-8685.
27. Medley QG, Kedersha N, O'Brien S et al. Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc. Natl Acad. Sci. USA 1996; 93; 685-689.
28. Felger RE, Macon WR, Kinney MC et al. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Am. J. Pathol. 1997; 150; 1893-1900.
29. Tao J, Shelat SG, Jaffe ES, Bagg A. Aggressive Epstein-Barr virus-associated, CD8+, CD30+, CD56+, surface CD3-, natural killer (NK)-like cytotoxic T-cell lymphoma. Am. J. Surg. Pathol. 2002; 26; 111-118.
30. Lanier LL, Spitz H, Phillips JH. The developmental relationship between NK cells and T cells. Immunol. Today 1992; 13; 392-395.
31. Nagler A, Lanier LL, Cwirla S, Phillips JH. Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 1989; 143; 3183-3191.
32. + cells. J. Immunol. 1990; 145; 3209-3215.
33. Kawano T, Cui J, Koezuka Y et al. CD1d-restricted and TCR-mediated activation of Vα14NKT cells by glycosylceramides. Science 1997; 278; 1626-1629.
34. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol. Today 2000; 21; 573-583.
35. Baker J, Verneris MR, Shizuru JA, Negrin RS. Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production. Blood 2001; 97; 2923-2931.
36. Mori KL, Egashira M, Oshimi K. Differentiation stage of natural killer cell lineage lymphoproliferative disorders based on phenotypic analysis. Br. J. Haematol. 2001; 115; 225-228.
37. Lin CW, Chen YH, Chuang YC, Liu TY, Hsu SM. CD94 transcripts imply a better prognosis in nasal-type extranodal NK/T-cell lymphopma. Blood 2003; 102; 2623-2631.
38. Haedicke W, Ho FC, Chott A et al. Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas. Blood 2000; 95; 3628-3630.
39. Harabuchi Y, Imai S, Wakashima J et al. Nasal T-cell lymphoma causally associated with Epstein-Barr virus. Cancer 1996; 77; 2137-2149.
40. Kanavaros P, Lescs MC, Briere J et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81; 2688-2695.
41. Nakamura S, Katoh E, Koshikawa T et al. Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese. Pathol. Int. 1996; 47; 38-53.
42. Li YX, Coucke PA, Li JY et al. Primary non-Hodgkin's lymphoma of the nasal cavity. Cancer 1998; 83; 449-456.
43. Palacios E, Restrepo S, Rojas R. Extramedullary plasmacytoma in the nasal cavity. Ear Nose Throat J. 2002; 81; 499-500.
44. Alexiou C, Kau RJ, Dietzfelbinger H et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer 1999; 85; 2305-2314.